KemPharm (KMPH) Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. SPY
7. TMUS
8. UNP
9. GOOGL
10. RNG

Go back to KemPharm (KMPH) Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS
(NASDAQ: KMPH) Delayed: 5.81 --0 (-0%)
Previous Close $5.81    52 Week High $20.60 
Open $38.30    52 Week Low $3.20 
Day High $5.81    P/E N/A 
Day Low $5.81    EPS $0.00 
Volume 176,325